We're currently fundraising! Become an early investor in Bioverge to own an expanding portfolio of leading TechBio startups through a single investment 🔬! Learn more and invest today 💸!

Why the FDA Was Right to Approve Biogen's Aduhelm

https://soundcloud.com/user-770548556/neil-sits-down-with-attorney-james-valentine-to-get-his-contrary-take-on-the-recent-controversal-fda-approval-of-biogens-alzheimers-drug-aduhelm James Valentine, an attorney with Hyman, Phelps & McNamara specializing in regulatory law, sits down with Neil to discuss the FDA’s accelerated approval of Biogen’s Aduhelm for Alzheimer’s disease and offers a contrarian take on the controversy.

1g9vsocptzevfhfskitq
1g9vsocptzevfhfskitq

https://soundcloud.com/user-770548556/neil-sits-down-with-attorney-james-valentine-to-get-his-contrary-take-on-the-recent-controversal-fda-approval-of-biogens-alzheimers-drug-aduhelm

James Valentine, an attorney with Hyman, Phelps & McNamara specializing in regulatory law, sits down with Neil to discuss the FDA’s accelerated approval of Biogen’s Aduhelm for Alzheimer’s disease and offers a contrarian take on the controversy.